(Q43274881)

18 November 2017

0 references

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis (English)

1 reference

18 November 2017

0 references

1 reference

1

1 reference

18 November 2017

2

Jan Buitelaar

1 reference

18 November 2017

10 September 2009

1 reference

European Child & Adolescent Psychiatry

18 November 2017

1 reference

18 November 2017

19

1 reference

18 November 2017

4

1 reference

18 November 2017

353-364

1 reference

https://scigraph.springernature.com/pub.10.1007/s00787-009-0054-3

18 November 2017

0 references

cites work

Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00787-009-0054-3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-009-0054-3

Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00787-009-0054-3

21 January 2018

12 December 2020

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1007%2FS00787-009-0054-3

Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis

21 January 2018

1 reference

12 December 2020

Comparing the efficacy of medications for ADHD using meta-analysis

1 reference

12 December 2020

Amphetamine: effects on catecholamine systems and behavior

1 reference

12 December 2020

Methylphenidate vs dexamphetamine: a clinical audit

1 reference

12 December 2020

Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis

1 reference

12 December 2020

Pharmacotherapy of attention deficit hyperactivity disorder

1 reference

12 December 2020

A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a reanalysis using drug-placebo and drug-drug response curve methodology

1 reference

12 December 2020

A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.

1 reference

12 December 2020

Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder

1 reference

12 December 2020

Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

12 December 2020

Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

1 reference

12 December 2020

Classroom academic performance: improvement with both methylphenidate and dextroamphetamine in ADHD boys.

1 reference

12 December 2020

A prospective study of stimulant response in preschool children: insights from ROC analyses

1 reference

12 December 2020

Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial

1 reference

12 December 2020

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

1 reference

12 December 2020

Measuring inconsistency in meta-analyses

1 reference

12 December 2020

Size of treatment effects and their importance to clinical research and practice

1 reference

12 December 2020

Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial

1 reference

12 December 2020

Measuring gain in the evaluation of medical technology. The probability of a better outcome

1 reference

12 December 2020

Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Norepinephrine transporter gene variation modulates acute response to D-amphetamine

1 reference

12 December 2020

The Drug-Placebo Response Curve: A New Method for Assessing Drug Effects in Clinical Trials

1 reference

12 December 2020

Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis

1 reference

12 December 2020

Differential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

The worldwide prevalence of ADHD: is it an American condition?

1 reference

12 December 2020

The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs

1 reference

12 December 2020

Mechanism of action of methylphenidate: insights from PET imaging studies

1 reference

12 December 2020

Pharmacology of the enantiomers of threo-methylphenidate

1 reference

12 December 2020

Response to methylphenidate in boys with attention-deficit hyperactivity disorder.

1 reference

12 December 2020

How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis

1 reference

12 December 2020

Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline

1 reference

12 December 2020

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

1 reference

12 December 2020

10.1007/S00787-009-0054-3

Identifiers

DOI

1 reference

PubMed ID

19763664

Dimensions Publication ID

18 November 2017

0 references

1 reference

PubMed ID

19763664